ArticlemBio2018
IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal
Open access · goldAbstract read
In one paragraph
Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 41 citations in OpenAlex.
- Vaccine-induced antibodies can limitmBio · 2026Article
- Current Applications and Immunological Considerations ofMicroorganisms · 2026Review
- Multivalent vaccines for invasiveInfection and immunity · 2026Review
- Characterization of a Luminescence-Based Serum Bactericidal Activity Assay for Human Sera Against a Panel ofMicroorganisms · 2025Article
- Review
- Bioengineering Outer-Membrane Vesicles for Vaccine Development: Strategies, Advances, and Perspectives.Vaccines · 2025Review
- Article
- Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.Applied microbiology and biotechnology · 2024Review
- Outer Membrane Vesicle Vaccine Platforms.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2024Review
- Article
- The Potential Role of Vaccines in Preventing Antimicrobial Resistance (AMR): An Update and Future Perspectives.Vaccines · 2023Review
- Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine againstInternational journal of molecular sciences · 2023Article
- Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses.Frontiers in immunology · 2023Article
- Extracellular vesicles elicit protective immune responses against Salmonella infection.Journal of extracellular vesicles · 2022Article
- Article
- Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients.Science translational medicine · 2022Article
- The Outer Membrane Vesicles ofPathogens (Basel, Switzerland) · 2022Article
- Towards a Four-Component GMMA-Based Vaccine againstVaccines · 2022Review
- Novel Simple Conjugation Chemistries for Decoration of GMMA with Heterologous Antigens.International journal of molecular sciences · 2021Article
- Stability of Outer Membrane Vesicles-Based Vaccines, Identifying the Most Appropriate Methods to Detect Changes in Vaccine Potency.Vaccines · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 3 institutions in 3 countries.
Anna E SchagerInstitute for Microbiology and Infection, School of Immunology and Immunotherapy, Institute for Biomedical Research, University of Birmingham, Birmingham, United Kingdom.
C Coral Dominguez-MedinaInstitute for Microbiology and Infection, School of Immunology and Immunotherapy, Institute for Biomedical Research, University of Birmingham, Birmingham, United Kingdom.
Francesca NecchiGSK Vaccines Institute for Global Health, Siena, Italy.
Francesca MicoliGSK Vaccines Institute for Global Health, Siena, Italy.
Yun Shan GohGSK Vaccines Institute for Global Health, Siena, Italy.
Margaret GoodallInstitute for Microbiology and Infection, School of Immunology and Immunotherapy, Institute for Biomedical Research, University of Birmingham, Birmingham, United Kingdom.
Adriana Flores-LangaricaInstitute for Microbiology and Infection, School of Immunology and Immunotherapy, Institute for Biomedical Research, University of Birmingham, Birmingham, United Kingdom.
Saeeda BobatInstitute for Microbiology and Infection, School of Immunology and Immunotherapy, Institute for Biomedical Research, University of Birmingham, Birmingham, United Kingdom.
Charlotte N L CookInstitute for Microbiology and Infection, School of Immunology and Immunotherapy, Institute for Biomedical Research, University of Birmingham, Birmingham, United Kingdom.
Melissa ArcuriInstitute for Microbiology and Infection, School of Immunology and Immunotherapy, Institute for Biomedical Research, University of Birmingham, Birmingham, United Kingdom.
Arianna MariniInstitute for Microbiology and Infection, School of Immunology and Immunotherapy, Institute for Biomedical Research, University of Birmingham, Birmingham, United Kingdom.
Lloyd D W KingInstitute for Microbiology and Infection, School of Immunology and Immunotherapy, Institute for Biomedical Research, University of Birmingham, Birmingham, United Kingdom.
Faye C MorrisInstitute for Microbiology and Infection, School of Immunology and Immunotherapy, Institute for Biomedical Research, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0002-9021-0452
Graham AndersonInstitute for Microbiology and Infection, School of Immunology and Immunotherapy, Institute for Biomedical Research, University of Birmingham, Birmingham, United Kingdom.
Kai-Michael ToellnerInstitute for Microbiology and Infection, School of Immunology and Immunotherapy, Institute for Biomedical Research, University of Birmingham, Birmingham, United Kingdom.
Ian R HendersonInstitute for Microbiology and Infection, School of Immunology and Immunotherapy, Institute for Biomedical Research, University of Birmingham, Birmingham, United Kingdom.
Constantino López-MacíasMedical Research Unit on Immunochemistry, National Medical Center "SigloXXI," Specialties Hospital, Mexican Institute for Social Security (IMSS), Mexico City, Mexico.
Calman A MacLennanGSK Vaccines Institute for Global Health, Siena, Italy.
Adam F CunninghamInstitute for Microbiology and Infection, School of Immunology and Immunotherapy, Institute for Biomedical Research, University of Birmingham, Birmingham, United Kingdom a.f.cunningham@bham.ac.uk.ORCID 0000-0003-0248-964X
University of Birmingham · GBToscana Life Sciences · ITMexican Social Security Institute · MX
Funding
Biotechnology and Biological Sciences Research Council BB/L009986/1Medical Research Council G1001390Medical Research Council MR/N000919/1Medical Research Council MR/N023706/1Medical Research Council MR/N027027/1Medical Research Council MR/P008852/1
Abstract
Antibodies acquired after vaccination or natural infection with Gram-negative bacteria, such as invasive
Indexed as
AnimalsAntibodies, BacterialAntigens, BacterialB-LymphocytesFemaleImmunoglobulin GLipopolysaccharidesMaleMiceO AntigensPorinsSalmonella InfectionsSalmonella typhimuriumSalmonella VaccinesAntibodies, BacterialAntigens, BacterialImmunoglobulin GLipopolysaccharidesO AntigensPorinsSalmonella VaccinesantibodiesB-cell responsesinfectionouter membrane vesiclesSalmonellavaccines
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.